We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Horizon to Acquire CombinatoRx Service Business and Assets from Zalicus

Horizon Discovery Group has agreed to acquire the CombinatoRx service business and related assets from Zalicus Inc for £4.7M.
News

Metabolon Enters into Collaboration with GSK

Agreement will see Metabolon provide metabolomic profiling services to GlaxoSmithKline.
News

Genetic Material Hitchhiking in Our Cells May Shape Physical Traits

Explaining the connection between genotype and phenotype must also consider genetic material that doesn’t come from an organism’s chromosomes at all.
News

Dangerous Nitrogen Pollution could be Halved

The most important fertilizer for producing food is, at the same time, one of the most important risks for human health: nitrogen.
News

Atlas Shows How Genes Affect Our Metabolism

New atlas of molecules paves the way for improved understanding of metabolic diseases.
News

Expanding the Power of RNAi

RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
News

The 2014 Annual MO BIO Microbiome Awards, Offering More Than $10,000 of Prizes

The Microbiome Awards aim to provide young, extraordinary scientists with funding and recognition to carry out scientific work in the field of microbiome research.
News

BD Receives FDA Clearance for Gastroenteritis Test

The FDA-cleared BD MAX™ Enteric Bacterial Panel for use on the BD MAX System.
News

Detection of Large Expansions in Myotonic Dystrophy Type 1

The aims of this study were to verify the validity of triplet primed-PCR for the diagnosis of patients presenting with DM1 clinical findings and to simplify the testing procedure.
News

Eurofins to Acquire ViraCor-IBT Laboratories

Company has signed a definitive agreement to acquire ViraCor-IBT Laboratories from majority owner Ampersand Capital and other shareholders for approximately $255m.
Advertisement